SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Progress Note 6 — Preventive Visit — Evel Knievel — True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

PatientEvel Knievel
Date of birth1938-10-17
IdentifiersMRN HR-RB001-SYN-TD; SSN (made up) 000-01-4927
Document date1996-09-21
AuthorDale Rasmussen, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Chief Complaint

Periodic adult preventive visit. [S]

History of Present Illness

Mr. Knievel is a 57-year-old retired stunt performer with compensated cirrhosis from hepatitis C, cured by 12 weeks of sofosbuvir-velpatasvir, who comes for his yearly preventive visit five weeks after the test that confirmed cure. He has had no alcohol since the start of treatment. He takes carvedilol 12.5 mg daily without dizziness, and had his zoledronic acid infusion in June without a reaction. His pain is about 4 of 10; he goes to the pool twice a week and walks 30 minutes on flat ground most days. He has had no falls since starting physical therapy. His glucose sensor shows no low readings. He has had no abdominal swelling, black stools, confusion or yellowing of the eyes. [S]

ElementDetail
VisitPeriodic adult preventive visit, age 57
LiverHepatitis C cured; compensated cirrhosis; carvedilol; next surveillance ultrasound in February
AlcoholNone since the start of treatment
MoodPHQ-2 0

Health risk assessment. Completed by the patient on the clinic's online form before the visit and reviewed with him by Dr. Rasmussen. [S]

DomainFinding
Self-rated healthGood; better than in years
PsychosocialBusy with appearances and travel; good support from family and friends
Substance useNo alcohol since February; never smoked; no drug use
Physical activityPool exercise twice a week; walks 30 minutes most days; some golf
NutritionThree meals and a late-evening snack; protein at each meal; less salt
SleepSix to seven hours; wakes with hip pain once a night
Falls and home safetyNo falls since physical therapy; grab bars and a shower chair; cane on long walks
DrivingDrives in daytime; always wears a seat belt
Activities of daily livingIndependent in all
Smoke alarms and firearmsSmoke alarms tested; no firearms at home

Review of Systems

SystemResultFinding
ConstitutionalNegativeEnergy better; no fever or weight loss
EyesNegativeNo vision change; retinal examination in June normal
Ears, nose, mouth, and throatNegativeNo hearing change or nosebleeds
CardiovascularNegativeNo chest pain, palpitations or leg swelling
RespiratoryNegativeNo cough or breathlessness
GastrointestinalNegativeNo abdominal swelling, black stools or vomiting blood
GenitourinaryNegativeNo urinary hesitancy, frequency or blood in the urine
MusculoskeletalPositiveHip, knee and back pain, about 4 of 10
IntegumentaryNegativeNo yellowing, itching or new skin lesions
NeurologicalNegativeNo confusion, sleep reversal or tremor
EndocrineNegativeNo low glucose readings
PsychiatricNegativeMood good; PHQ-2 0

12 systems reviewed. [S]

Medications

MedicationFrequencyRouteDatesStatusEvidence
Metformin 1000 mg oral tablet, one tablet by mouth twice daily with mealsOne tablet twice daily with breakfast and supperOral route1991-03-01activeS
Ibuprofen 800 mg oral tablet, one tablet three times a day for joint and back painOne tablet three times a dayOral route1994-06-01 to 1996-01-12completedS
Omeprazole 20 mg delayed-release oral capsule, one capsule daily for indigestion from ibuprofenOne capsule daily before breakfastOral route1994-06-01 to 1996-01-12completedS
Acetaminophen 500 mg oral tablet, two tablets by mouth up to twice a day as needed for pain, no more than 2 g a dayTwo tablets up to twice a day as needed; no more than 2 g a dayOral route1996-01-12activeS
Diclofenac sodium 1% topical gel, 4 g to the knees up to four times a day4 g to each knee up to four times a dayTopical route1996-01-12activeS
Carvedilol 6.25 mg oral tablet, one tablet dailyOne tablet dailyOral route1996-01-26 to 1996-02-23completedS
Carvedilol 12.5 mg oral tablet, one tablet dailyOne tablet dailyOral route1996-02-23activeS
Atorvastatin 20 mg oral tablet, one tablet dailyOne tablet dailyOral route1996-01-26activeS
Sofosbuvir 400 mg and velpatasvir 100 mg oral tablet, one tablet daily for 12 weeksOne tablet daily for 12 weeksOral route1996-02-23 to 1996-05-17completedS
Cholecalciferol (vitamin D3) 50 mcg (1970 units) oral capsule, one capsule dailyOne capsule dailyOral route1996-02-23activeS
Zoledronic acid 5 mg in 100 mL, intravenous infusion over at least 15 minutes, once a yearOnce a yearIntravenous route1996-06-01activeS

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Vital Signs

DateMeasureValueUnitProvenance
1996-09-21Body height178cmS
1996-09-21Body weight82.4kgS
1996-09-21Body mass index (BMI) [Ratio]26kg/m2S
1996-09-21Systolic blood pressure122mm[Hg]S
1996-09-21Diastolic blood pressure74mm[Hg]S
1996-09-21Heart rate62/minS
1996-09-21Respiratory rate14/minS
1996-09-21Body temperature36.6CelS
1996-09-21Oxygen saturation in Arterial blood by Pulse oximetry98%S

Results

DateMeasureValueUnitReference rangeFlagProvenance
1996-09-21Cholesterol [Mass/volume] in Serum or Plasma148mg/dL<=199 mg/dLNormalS
1996-09-21Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation68mg/dLGoal below 100 mg/dL in diabetes, below 70 if higher riskNormalS
1996-09-21Cholesterol in HDL [Mass/volume] in Serum or Plasma42mg/dL>=40 mg/dLNormalS
1996-09-21Triglyceride [Mass/volume] in Serum or Plasma140mg/dL<=149 mg/dLNormalS
1996-09-21Prostate specific Ag [Mass/volume] in Serum or Plasma1.3ng/mL<=4 ng/mLNormalS
1996-09-21Patient Health Questionnaire 2 item (PHQ-2) total score [Reported]0{score}S

Physical Exam

Vital signs recorded on 1996-09-21; see the Vital Signs section. [S]

SystemFinding
ConstitutionalWell; weight 82.4 kg; blood pressure 122/74; pulse 62
EyesNo scleral icterus
SkinA few spider angiomas on the chest, fewer than before; palmar erythema; no jaundice
CardiovascularRegular rhythm; no murmur
RespiratoryClear
AbdomenSpleen tip palpable; no ascites or tenderness
MusculoskeletalReduced hip rotation on both sides; old fracture deformities of the forearms; knees with crepitus
FeetMonofilament sensation intact; pulses present; no ulcers
NeurologicalNo asterixis; gait slow but steady; Timed Up and Go 11 seconds
PsychiatricCheerful and blunt

Problems

ProblemClinical statusVerificationCodeProvenance
Raised transaminases (ALT 88, AST 96 U/L) and low platelets (118) on today's tests, with spider angiomas and palmar erythema, in a man of 57 who received many blood transfusions after crashes before 1962 and drinks most evenings: chronic liver disease, most likely hepatitis C, must be excluded. Hepatitis C antibody with reflex RNA, hepatitis A and B serology, HIV, liver ultrasound and hepatology review orderedresolvedconfirmed R74.01S — Synthetic presenting problem; no symptom or result of his real illness was made public. Superseded at the hepatology consultation.
Chronic hepatitis C, genotype 1a, treatment-naive, HCV RNA 2.35 million IU/mL, likely acquired through blood transfusions after crashes; synthetic modern detail linked to his publicly reported transfusion-acquired hepatitis Cresolvedconfirmed B18.2S — Synthetic genotype, viral load and timing; his hepatitis C and its likely transfusion source are documented (D).
Compensated cirrhosis from hepatitis C, with alcohol as a cofactor: liver stiffness 26.8 kPa, FIB-4 4.94, nodular liver and a 14.2 cm spleen on ultrasound, platelets 118; Child-Pugh A5, MELD-Na 8; no ascites, encephalopathy, jaundice or bleedingactiveconfirmed K74.69S — Synthetic stage of liver disease linked to his documented hepatitis C and later liver transplant.
Clinically significant portal hypertension in compensated cirrhosis (liver stiffness 25 kPa or more), treated with carvedilol without screening endoscopy (Baveno VII)activeconfirmed K76.6S — Synthetic finding at the hepatology consultation.
Type 2 diabetes on metformin, A1c 7.4%activeconfirmed E11.65S — Synthetic; diabetes is documented only in his last years (D), and placing it at 57 is a synthetic choice.
Chronic pain in the back, hips, pelvis and knees after dozens of fractures from stunt crashes, including a broken pelvis; ibuprofen stopped, and managed without oral NSAIDs or opioidsactiveconfirmed G89.29S — Synthetic pain at the index age, anchored to his documented fractures and the pain of his later years.
Osteoporosis in a man with cirrhosis, prior heavy alcohol use and dozens of old fractures: femoral neck T-score -2.6, lumbar spine -1.9activeconfirmed M81.8S — Synthetic bone density result.
Vitamin D deficiency (25-hydroxyvitamin D 17 ng/mL)resolvedconfirmed E55.9S — Synthetic finding before the bone density scan.

Assessment and Plan

Personalized prevention plan. A written copy was given to the patient. [S]

ServiceStatusDetail
Blood pressure screeningCompleted today122/74 mmHg on carvedilol
Depression screeningCompleted todayPHQ-2 score 0; PHQ-9 3 a month ago
Unhealthy alcohol use screening and counselingCompleted todayNo alcohol since February; abstinence reinforced
Tobacco useCompleted todayNever
Colorectal cancer screeningOrderedNever screened; colonoscopy ordered
Prostate cancer screeningCompleted todayShared decision; he chose testing; PSA 1.3 ng/mL
Lung cancer screeningNot indicatedNever smoked
Diabetes and lipid careCompleted todayGlucose management indicator 6.8%; LDL 68 mg/dL on atorvastatin; urine albumin normal in January
Hepatitis C, hepatitis B and HIV screeningUp to dateHepatitis C treated and cured; hepatitis B and HIV negative in January
Liver cancer surveillanceUp to dateUltrasound and alpha-fetoprotein in August; next in February
OsteoporosisUp to dateZoledronic acid in June; bone density again in two years
Fall riskCompleted todayNo falls since physical therapy; Timed Up and Go 11 seconds
Influenza, pneumococcal, zoster and Tdap vaccinesCompleted todayGiven today
Hepatitis A and B vaccinesUp to dateBoth two-dose series complete
COVID-19 vaccine, this seasonDueAt his pharmacy this autumn
Dental and eye examinationsUp to dateDental review before zoledronic acid in May; retinal examination in June

Immunizations given today: Influenza vaccine, inactivated, trivalent, preservative free, this season; Pneumococcal conjugate vaccine PCV20; Recombinant zoster vaccine, dose 1 of 2; Tetanus, diphtheria, and acellular pertussis vaccine (Tdap) [S]

Guideline basis: Singal AG, et al. AASLD Practice Guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma. Hepatology 2023;78(6):1922-1965 (PMID 37199193) (2023); American Diabetes Association. 4. Comprehensive Medical Evaluation and Assessment of Comorbidities: Standards of Care in Diabetes-2026. Diabetes Care 2026;49(Suppl 1):S61-S88 (PMID 41358897) (2026); Unhealthy Alcohol Use in Adolescents and Adults: Screening and Behavioral Counseling Interventions (2018); Adult Immunization Schedule by Medical Condition and Other Indication (2026); Medicare Preventive Services reference: visit templates, screening cascades, and documentation elements (2026); USPSTF A and B Recommendations (2026); Colorectal Cancer: Screening (2021); Prostate Cancer: Screening (2018)

Follow-up: Colonoscopy in the next two months. Liver ultrasound with alpha-fetoprotein in February. Hepatology review with liver stiffness a year after cure. Second zoster dose in two to six months. Next preventive visit in one year. [S]

Advance Care Planning

Voluntary advance care planning discussion of about 20 minutes, with his consent. He wants full treatment, including a liver transplant evaluation if his liver ever fails, and wants to be told plainly how he is doing. He named a health care agent, recorded in the confidential part of the chart and not named here. He chose not to complete other treatment preferences today. To be revisited yearly or if his health changes. [S]